Answers are grounded in this paper and cite their sources.
Circulating HBV RNAs have been proposed as a biomarker that reflects the transcriptional activity of covalently closed circular DNA (cccDNA) and may help to evaluate HBV treatment activity. Different research assays have been proposed and, although two PCR-based research use only investigational assays have been developed, the lack of standardized protocols represents an important limitation. Here we have designed and generated a stable clonal cell line producing an RNA-based standard for the calibration of PCR-based circulating HBV RNA assays.
No takes yet. Share an insight, caveat, or question.
Paturel et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: